SCHEDULE 13G: Nissim Daniel Discloses 9.99% Stake in Clearmind Medicine
Beneficial Ownership Disclosure
Nissim Daniel has reported beneficial ownership of 9.99% of Clearmind Medicine Inc.'s common shares, totaling 3,307,291 shares.
Summary
- Nissim Daniel, an individual from Israel, has filed a Schedule 13G indicating beneficial ownership in Clearmind Medicine Inc.
- The filing reports that Nissim Daniel beneficially owns 3,307,291 common shares of Clearmind Medicine Inc.
- This ownership represents 9.99% of the total outstanding common shares of the Issuer.
- The percentage is calculated based on 33,106,024 common shares outstanding, as reported by Clearmind Medicine Inc. in a prospectus supplement filed on November 19, 2025.
- Nissim Daniel holds sole voting power and sole dispositive power over all 3,307,291 shares.
- The securities were not acquired or held for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.
Sentiment
Score: 5
Explanation: The filing is a neutral, factual disclosure of beneficial ownership and does not contain information that would inherently sway sentiment positively or negatively.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of a significant ownership stake by an individual investor in a publicly traded company. It does not provide specific industry context beyond the fact that Clearmind Medicine Inc. is a public entity with common shares traded.
Stakeholder Impact
- Shareholders: Disclosure of a significant individual stake can provide transparency regarding major investors and potentially influence market perception of the company's ownership structure.
Key Dates
| Date | Description |
|---|---|
| 11/19/2025 | Date of event which requires filing of this statement; also the date of the prospectus supplement reporting outstanding shares. |
| 11/28/2025 | Date the Schedule 13G was signed by Nissim Daniel. |
Keywords
Clearmind Medicine Inc., Nissim Daniel, Beneficial Ownership, Schedule 13G, Common Shares, Equity Stake, Investment Disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.